135 related articles for article (PubMed ID: 37751183)
21. Systemic Chemotherapies Retain Antitumor Activity in Desmoid Tumors Independent of Specific Mutations in CTNNB1 or APC: A Multi-institutional Retrospective Study.
Nathenson MJ; Hu J; Ratan R; Somaiah N; Hsu R; DeMaria PJ; Catoe HW; Pang A; Subhawong TK; Amini B; Sweet K; Feister K; Malik K; Jagannathan J; Braschi-Amirfarzan M; Sheren J; Caldas Y; Moreno Tellez C; Rosenberg AE; Lazar AJ; Maki RG; Benedetto P; Cohen J; Trent JC; Ravi V; Patel S; Wilky BA
Clin Cancer Res; 2022 Sep; 28(18):4092-4104. PubMed ID: 35180772
[TBL] [Abstract][Full Text] [Related]
22. Desmoid Fibromatosis With TP53 Mutation and Striking Nuclear Pleomorphism.
Foster CR; Strauss M; Hornick JL; Habeeb O
Int J Surg Pathol; 2023 Dec; 31(8):1565-1571. PubMed ID: 36908221
[TBL] [Abstract][Full Text] [Related]
23. A germline mutation at the extreme 3' end of the APC gene results in a severe desmoid phenotype and is associated with overexpression of beta-catenin in the desmoid tumor.
Couture J; Mitri A; Lagace R; Smits R; Berk T; Bouchard HL; Fodde R; Alman B; Bapat B
Clin Genet; 2000 Mar; 57(3):205-12. PubMed ID: 10782927
[TBL] [Abstract][Full Text] [Related]
24. Characteristics of cultured desmoid cells with different CTNNB1 mutation status.
Hamada S; Urakawa H; Kozawa E; Arai E; Ikuta K; Sakai T; Ishiguro N; Nishida Y
Cancer Med; 2016 Feb; 5(2):352-60. PubMed ID: 26686699
[TBL] [Abstract][Full Text] [Related]
25. Radiation-induced Sarcomas Occurring in Desmoid-type Fibromatosis Are Not Always Derived From the Primary Tumor.
Verschoor AJ; Cleton-Jansen AM; Wijers-Koster P; Coffin CM; Lazar AJ; Nout RA; Rubin BP; Gelderblom H; Bovée JV
Am J Surg Pathol; 2015 Dec; 39(12):1701-7. PubMed ID: 26414222
[TBL] [Abstract][Full Text] [Related]
26. Droplet Digital PCR (ddPCR) as a Novel Technology in Detecting CTNNB1 Mutations in Desmoid Fibromatosis.
Gandhi J; Kao E; Wu Y; Mantilla JG; Ricciotti RW; Bandhlish A; Liu YJ; Chen EY
Appl Immunohistochem Mol Morphol; 2022 Nov-Dec 01; 30(10):662-667. PubMed ID: 36227098
[TBL] [Abstract][Full Text] [Related]
27. Sinonasal Myxoma: A Distinct Entity or a Myxoid Variant of Desmoid Fibromatosis?
Velez Torres JM; Mata DA; Briski LM; Green DC; Cloutier JM; Kerr DA; Montgomery EA; Rosenberg AE
Mod Pathol; 2023 Jul; 36(7):100189. PubMed ID: 37059229
[TBL] [Abstract][Full Text] [Related]
28. Risk factors predicting desmoid occurrence in patients with familial adenomatous polyposis: a meta-analysis.
Sinha A; Tekkis PP; Gibbons DC; Phillips RK; Clark SK
Colorectal Dis; 2011 Nov; 13(11):1222-9. PubMed ID: 20528895
[TBL] [Abstract][Full Text] [Related]
29. Correlation of CTNNB1 Mutation Status with Progression Arrest Rate in RECIST Progressive Desmoid-Type Fibromatosis Treated with Imatinib: Translational Research Results from a Phase 2 Study of the German Interdisciplinary Sarcoma Group (GISG-01).
Kasper B; Gruenwald V; Reichardt P; Bauer S; Hohenberger P; Haller F
Ann Surg Oncol; 2016 Jun; 23(6):1924-7. PubMed ID: 26861905
[TBL] [Abstract][Full Text] [Related]
30. Desmoid Tumor of the Rectus Abdominis with Urinary Bladder Involvement: A Case Report and Review of Literature.
Alfentoukh M; Salih A; Hassan ME; Alghamdi O; Alkhawaja KA; Ibrahim MA; Sabir EI
Gulf J Oncolog; 2023 Jan; 1(41):100-106. PubMed ID: 36804164
[TBL] [Abstract][Full Text] [Related]
31. Tailored Beta-catenin mutational approach in extra-abdominal sporadic desmoid tumor patients without therapeutic intervention.
van Broekhoven DL; Grünhagenl DJ; van Dalen T; van Coevorden F; Bonenkamp HJ; Been LB; Bemelmans MH; Dijkstra SD; Colombo C; Gronchi A; Verhoef C
BMC Cancer; 2016 Aug; 16(1):686. PubMed ID: 27565718
[TBL] [Abstract][Full Text] [Related]
32. Near universal detection of alterations in CTNNB1 and Wnt pathway regulators in desmoid-type fibromatosis by whole-exome sequencing and genomic analysis.
Crago AM; Chmielecki J; Rosenberg M; O'Connor R; Byrne C; Wilder FG; Thorn K; Agius P; Kuk D; Socci ND; Qin LX; Meyerson M; Hameed M; Singer S
Genes Chromosomes Cancer; 2015 Oct; 54(10):606-15. PubMed ID: 26171757
[TBL] [Abstract][Full Text] [Related]
33. CTNNB1 and APC Mutations in Sinonasal Myxoma : Expanding the Spectrum of Tumors Driven By WNT/β-catenin Pathway.
Chen S; Gallant S; Cunningham MJ; Robson CD; Church AJ; Perez-Atayde AR; Al-Ibraheemi A
Am J Surg Pathol; 2023 Nov; 47(11):1291-1300. PubMed ID: 37589277
[TBL] [Abstract][Full Text] [Related]
34. Cutaneous desmoid-type fibromatosis: A rare case with molecular profiling.
Aghighi M; Cloutier JM; Hoover WD; Roy K; Lo AA; Brown RA
J Cutan Pathol; 2021 Sep; 48(9):1185-1188. PubMed ID: 33978242
[TBL] [Abstract][Full Text] [Related]
35. The Prognostic Role of β-Catenin Mutations in Desmoid-type Fibromatosis Undergoing Resection Only: A Meta-analysis of Individual Patient Data.
Timbergen MJM; Colombo C; Renckens M; Kim HS; Rosmalen JV; Salas S; Mullen JT; Colombo P; Nishida Y; Wiemer EAC; Verhoef C; Sleijfer S; Gronchi A; Grünhagen DJ
Ann Surg; 2021 Jun; 273(6):1094-1101. PubMed ID: 31804402
[TBL] [Abstract][Full Text] [Related]
36. Lack of Prognostic Value of CTNNB1 Mutation Profile in Desmoid-Type Fibromatosis.
Penel N; Bonvalot S; Bimbai AM; Meurgey A; Le Loarer F; Salas S; Piperno-Neumann S; Chevreau C; Boudou-Rouquette P; Dubray-Longeras P; Kurtz JE; Guillemet C; Bompas E; Italiano A; Le Cesne A; Orbach D; Thery J; Le Deley MC; Blay JY; Mir O
Clin Cancer Res; 2022 Sep; 28(18):4105-4111. PubMed ID: 35294527
[TBL] [Abstract][Full Text] [Related]
37. Sporadic desmoid tumor in an Ashkenazi patient homozygous for the APC*I1307K gene mutation.
Zauber P; Sabbath-Solitare M; Stephen PM; Chamberlain R; Chong G; Foulkes WD; Bishop T
Acta Oncol; 2008; 47(6):1158-61. PubMed ID: 18770064
[No Abstract] [Full Text] [Related]
38. Breast desmoid tumor management in France: toward a new strategy.
Duazo-Cassin L; Le Guellec S; Lusque A; Chantalat E; Laé M; Terrier P; Coindre JM; Boulet B; Le Boulc'h M; Gangloff D; Meresse T; Chaput B; Al Ali A; Rimareix F; Bonvalot S; Vaysse C
Breast Cancer Res Treat; 2019 Jul; 176(2):329-335. PubMed ID: 31016642
[TBL] [Abstract][Full Text] [Related]
39. Desmoid-type fibromatosis of the head and neck region in the paediatric population: a clinicopathological and genetic study of seven cases.
Flucke U; Tops BB; van Diest PJ; Slootweg PJ
Histopathology; 2014 May; 64(6):769-76. PubMed ID: 24206198
[TBL] [Abstract][Full Text] [Related]
40. Is mutation analysis of β-catenin useful for the diagnosis of desmoid-type fibromatosis? A systematic review.
Sakai T; Hamada S; Koike H; Shimizu K; Yoshida M; Nishida Y
Jpn J Clin Oncol; 2020 Sep; 50(9):1037-1042. PubMed ID: 32533146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
